SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FNS who wrote (613)4/2/1998 11:33:00 AM
From: Robohogs  Read Replies (1) of 965
 
CNTO will have hard time staying above $40 given the news. CORR has been approved for unstable angina, an indication not even yet in phase III testing for CNTO. The market is 4x the size of the markets for which CNTO is approved. Looks like CNTO won the first battle but lost the war. Now all we need is for no partner for Avakine and no approval for Avakine. I am selling this morning.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext